Back to results
US 2021/0260150 A1Published application
Dry powder formulation of caveolin-1 peptides and methods of use thereof
AssigneesBoard of Regents, The University of Texas System, Lung Therapeutics, Inc.
InventorsRobert O. WILLIAMS, III, Alan B. WATTS, Yajie ZHANG, Sawittree SAHAKIJPIJARN, Dale CHRISTENSEN, John J. KOLENG
Life of this patent
Estimating the term…
Abstract
Provided herein are compositions comprising caveolin-1 (Cav-1) peptides. Further provided are methods of using the Cav-1 peptides for the treatment of lung infections or acute or chronic lung injury, particularly lung fibrosis.
Claims80
A pharmaceutical composition comprising a dry powder of a peptide, said peptide comprising a sequence of anyone of SEQ ID NOs:
- 2-20.
A pharmaceutical composition, comprising a peptide of SEQ ID Nos:
- 2-20 formulated a milled dry powder having a respirable particle size.
Dependencies are inferred from the claim text.